Oxford Global Conferences Ltd are proud to present the 2nd Annual Drug Discovery USA Congress, taking place on the 29th & 30th October, 2015 at The Westin Boston Waterfront Hotel in Boston, Massachusetts, USA. Our Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.
The drug discovery landscape is changing rapidly. With the cost of bringing a drug to market rising rapidly, researchers are seeking innovative ways to increase the efficiency of their R&D pipelines. On the first day of our Drug Discovery USA Congress our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. Our renowned speakers will explore research strategies such as repositioning existing drug products, approaches for targeting PPI and GPCRs and incorporating genomic technologies into discovery research.
Day one features an exciting stream covering the latest screening and assay technologies, such as high content analysis, the latest mass spectroscopy tools and using stem and primary cells for physiologically relevant disease models.
The pharma industry is seeing an increased focus on strengthening data and knowledge management in R&D pipelines to make the most of discovery data. Researchers are seeking new techniques to manage complex early stage discovery portfolios and for library optimisation.
On day two our Congress features an exciting stream dedicated to supporting innovation with informatics tools in which we will explore new data analysis and integration platforms, as well as ideas for efficient data exchange and pre-competitive collaboration. Day two will also host discussions about the latest research in the discovery chemistry field, with exciting case studies covering protein-protein interaction, water mediated binding, computational tools for drug design as well as fragment based drug design.
Stream 1: Target Based Discovery
- Phenotypic vs target-based discovery
- Reviving existing drug products: using omics to advance repurposing
- Accelerated target based discovery using genomic technologies
- New methods to target GPCRs
- Lead Generation
Stream 2: Screening & Assays: Enabling Technologies
- High content analysis: live cell imaging, 3D cell based assays, flow cytometry
- Developing disease relevant assays
- iPSC and primary cells: physiologically relevant assays
- Technology platform case studies: NMR & SPR
Stream 1: Discovery Chemistry & Drug Design
- Water mediated binding
- Advances in computational chemistry & knowledge-based design
- De-risking through design: achieving selectivity and specificity
- Increasing molecular complexity
- GPCR structure-guided design
Stream 2: Supporting Innovation: Translational Approaches & Informatics Tools
- Making the most of discovery data: compound optimisation and safety assessment
- Utilising predictive technologies
- New data analysis and integration platforms
- Fostering innovation through improved knowledge management and standardised data exchange
Associate Vice President and Head, Structural Chemistry, Merck Research Laboratories
Chris De Savi
Associate Director, Chemistry, AsztraZeneca
Dean G. Brown
Director Infection Chemistry, AstraZeneca
Assistant Professor, Harvard Medical School
Associate Research Fellow, Worldwide Medicinal Chemistry, Pfizer
Associate Research Fellow, Pfizer
Vice President, Research and Discovery, Ambrx
Director, Primary Pharmacology Group, UCB
Vice President, Global Functional Head, Janssen
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
How to submit your poster
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation
- Mailing address, Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.
To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!